A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

For years Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their sights - trying to capture the ...

ZYUS Life Sciences Corporation (the "Company") , a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, today ...

A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...

A collaborative study led by biomedical researchers Chris Lengner and M. Andrés Blanco at the School of Veterinary Medicine at the University of Pennsylvania has identified two genes that suppress ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

Researchers developed Bits2Bonds, a platform that merges molecular dynamics simulations with machine learning to design new ...

Exa-cel is the first FDA-approved therapy utilizing CRISPR/Cas9, a type of gene editing technology through which patients' ...

Exagamglogene autotemcel helped children with beta thalassemia achieve transfusion independence and prevented vaso-occlusive ...